Latest Period
Q4 2025
Security Snapshot
Cellectar Biosciences, Inc. - Common Shares (CLRB) Institutional Ownership
CUSIP: 15117F880
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
19
Shares (Excl. Options)
336,454
Price
$2.95
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Shares
- Symbol
- CLRB on Nasdaq
- Shares outstanding
- 4,338,395
- Price per share
- $2.74
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 336,454
- Total reported value
- $992,540
- % of total 13F portfolios
- 0%
- Share change
- +50,684
- Value change
- -$210
- Number of holders
- 19
- Price from insider filings
- $2.74
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- CLRB - Cellectar Biosciences, Inc. - Common Shares is tracked under CUSIP 15117F880.
- 19 institutions reported positions in Q4 2025.
- 5 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 19 to 2 between Q4 2025 and Q1 2026.
- Reported value moved from $992,540 to $47,907.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 19 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 15117F880?
CUSIP 15117F880 identifies CLRB - Cellectar Biosciences, Inc. - Common Shares in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 15117F880:
Significant Owners of Cellectar Biosciences, Inc. - Common Shares (CLRB) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Hexstone Capital LLC | 4.9% | -12% | $553,293 | +$169,293 | 216,130 | +44% | Hexstone Capital LLC | 31 Dec 2025 |
| Bleichroeder LP | 4.6% | -24% | $760,000 | 200,000 | 0% | Bleichroeder LP | 31 Dec 2025 | |
| INTRACOASTAL CAPITAL, LLC | 5% | 140,101 | Mitchell P. Kopin | 01 Jul 2025 | ||||
| LYTTON LAURENCE W | 1.6% | $250,788 | 51,391 | LYTTON LAURENCE W | 30 Jun 2025 | |||
| Nantahala Capital Management, LLC | 0.06% | $5,412 | 1,109 | Nantahala Capital Management, LLC | 30 Jun 2025 |
As of 31 Dec 2025, 19 institutional investors reported holding 336,454 shares of Cellectar Biosciences, Inc. - Common Shares (CLRB). This represents 7.8% of the company’s total 4,338,395 outstanding shares.